Acerus Pharma - Company & Market Research Reports

Founded in 2008, Acerus Pharmaceuticals focuses on the therapeutic areas of Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction). It has developed products for male hypogonadism, women’s hormone replacement therapy, and female sexual dysfunction. The company’s approved products include Natesto, a bioadhesive intranasal gel formulation of testosterone; and Estrace, an oral tablet for the symptomatic relief of menopausal symptoms. Acerus is headquartered in Mississauga, Canada.